Pim kinases, including Pim-1, Pim-2 and Pim-3, belong to a distinctive serine/ threonine protein-kinase family. They are involved in cytokine-induced signal transduction and the development of lymphoid malignancies. Their kinase domains are highly homologous to one another, but share low sequence identity to other kinases. Speci®cally, there are two proline residues in the conserved hinge-region sequence ERPXPX separated by a residue that is non-conserved among Pim kinases. Full-length human Pim-1 kinase (1±313) was cloned and expressed in Escherichia coli as a GST-fusion protein and truncated to Pim-1 (14±313) by thrombin digestion during puri®cation. The Pim-1 (14±313) protein was puri®ed to high homogeneity and monodispersity. This protein preparation yielded small crystals in the initial screening and large crystals after optimization. The large crystals of apo Pim-1 enzyme diffracted to 2.1 A Ê resolution and belong to space group P6 5 , with unit-cell parameters a = b = 95.9, c = 80.0 A Ê , = 120 and one molecule per asymmetric unit.
Introduction
Pim-1 is a serine/threonine protein kinase (Saris et al., 1991) with oncogenic function. It was originally identi®ed as a common integration site in Moloney murine leukemia virus (MMLV) induced T-cell lymphomas (Cuypers et al., 1984) . Overexpression of Pim-1 in mice resulted in susceptiblity to lymphomagenesis, which is likely to occur through a synergistic effect between Pim-1 and c-myc (van Lohuizen et al., 1989) . In humans, abnormal Pim-1 expression was detected in patients with lymphoma (Yoshida et al., 1999) and leukemia (Amson et al., 1989) . Pim-2 was also identi®ed as a common insertion site for MMLV and possessed similar oncogenic functions to Pim-1 (Breuer et al., 1989; van der Lugt et al., 1995) . Pim-3 has not been as well studied as Pim-1 and Pim-2, but is believed to have overlapping functions with Pim-1 and Pim-2.
Pim-1 plays a role in cell-growth control and survival (Wang et al., 2001) . Expression of Pim-1 is induced by a variety of growth factors, cytokines and mitogens, suggesting that Pim-1 may be involved in signal transduction initiated from these factors. Recently, mice de®-cient in all Pim kinases were shown to have reduced body size throughout their life span and the hematopoietic cell populations from these mice were defective in response to a subset of growthfactor stimulation (Mikkers et al., 2004) . In hematopoietic cells, overexpression of Pim-1 enhances cellular survival, reportedly by protecting these cells from apoptosis induced by cytokine withdrawal (Lilly et al., 1999; Shirogane et al., 1999) , glucocorticoids (Moroy et al., 1993) and genotoxic stress (Pircher et al., 2000) .
At the sequence level, Pim-2 and Pim-3 have 61 and 71% identity to Pim-1 (Allen & Berns, 1996) , suggesting that Pim kinases have similar three-dimensional structures. However, they are less than 30% identical in sequence to other known protein kinases. The Pimfamily kinases also share a consensus hinge-region sequence ERPXPX, which is quite unique because of the two proline residues. This unique sequence may lead to a hinge-region architecture that is distinct from other kinase hinge regions (Knighton et al., 1991; Johnson et al., 1996) . Therefore, structure elucidation of Pim-1 kinase should provide structural insights into Pim-1 as well as Pim-2 and Pim-3 kinases and the precise hinge-region conformation of Pim-1 kinase should greatly bene®t structure-based drug-design efforts targeting any of the Pim kinases. Here, we report the cloning, expression, crystallization and preliminary crystallographic analysis of human Pim-1 kinase.
Material and methods

Cloning and expression
The full-length Pim-1 cDNA was ampli®ed by PCR using IMAGE clone 4591723 (GenBank entry BC020224.1) as a template. The forward and reverse primers are 5 H -GGG GAA TTC ATG CTC TTG TCC AAA ATC-3 H and 5 H -GGG GAA GCT TCT ATT TGC TGG GCC CCG GCG AC-3 H , which contain the restriction sites for EcoRI and HindIII, respectively (in bold). The PCR-ampli®ed DNA fragment was puri®ed, digested with EcoRI and HindIII and ligated into pET41a vector (Novagen). The ligated vector carries a GST tag, a His tag and an S tag that are in tandem and N-terminal to the full-length Pim-1 gene, with an engineered thrombin-cleavage site between the last two tags. The cloned Pim-1 gene was veri®ed by sequencing.
The pET41a-Pim1 construct was expressed in Escherichia coli strain BL21 Star (DE3) pLysS (Invitrogen) in LB media. A 0.5 ml aliquot of a frozen glycerol stock was used to inoculate four 500 ml LB cultures containing 50 mg l À1 kanamycin and 34 mg l À1 chloramphenicol. These inoculation cultures were grown overnight at 310 K. The cultures were then used to inoculate a 15 l stirred tank fermentor at 310 K. When the OD 600 of the 15 l culture reached 1.0, the temperature was reduced to 298 K and the culture was induced with 0.5 mM IPTG. The culture was harvested after 3 h induction. A typical fermentation yielded about 55 g of cell mass. The cell mass was frozen in liquid nitrogen and stored at 193 K until use.
Purification
Brie¯y, Pim-1 kinase was puri®ed using GST-af®nity chromatography,`on-resin' thrombin cleavage and anion-exchange and size-exclusion chromatography (SEC) at 277 K. The protein concentrations were calculated from the absorption at 280 nM wavelength (A 280 ) using a calculated molar extinction coef®cient value of 49 510 (1 mg ml À1 = 1.5 unit of A 280 ). About 60 g cell paste was resuspended in 120 ml lysis buffer containing 20 mM Tris pH 8.0, 500 mM NaCl, 2 mM CaCl 2 , 5 mM DTT, 5 mg ml À1 leupeptin, 5 mg ml À1 pepstatin, 1 mM p-toluenesulfonyl chloride (PMSCl) and 10 units ml À1 DNAse. The suspension was then passed through a cell disruptor three times followed by centrifugation at 48 000g for 15 min. The supernatant was collected and immediately loaded at 4 ml min À1 onto a pre-washed XK50 column (Amersham) packed with 50 ml Glutathione-Sepharose 4B resin (GST-resin, Amersham). The loaded resin was immediately washed ®rst with 400 ml of a buffer containing 20 mM Tris pH 8.0, 500 mM NaCl, 2 mM CaCl 2 , 5 mM DTT at 4 ml min À1 and 1 ml min À1 (for the last 100 ml), then with 120 ml QA buffer (20 mM Tris pH 8.0, 50 mM NaCl, 5 mM CaCl 2 , 5 mM DTT). The GST-resin bound with Pim-1 fusion protein was incubated overnight with 5000 units of thrombin (Sigma-Aldrich) dissolved in 10 ml QA buffer. The digested Pim-1 was eluted from the GST-resin using QA buffer and peak fractions were loaded directly onto a pre-equilibrated (QA buffer) 8 ml Mono-Q column (Amersham) for anion-exchange chromatography. The Pim-1 protein eluted between 150 and 250 mM NaCl using a 0±1 M gradient in ten column volumes. Most fractions contained more than four major bands of protein on SDS±PAGE, three of which are close to the size of Pim-1 protein. These fractions were pooled (50 ml) and digested again in solution using 10 000 units of thrombin overnight. The re-digested sample was diluted and subjected to anion-exchange chromatography as described above. The peak fractions were pooled (40 ml, 1 mg ml
À1
) and concentrated to about 4.5 mg ml À1 for SEC. About 3 ml of the concentrated sample was loaded onto a pre-equilibrated Superdex-75 (preparative, 120 ml resin) column (Amersham) followed by elution using S buffer (20 mM Tris pH 8.0, 200 mM NaCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 5 mM DTT). The puri®ed Pim-1 sample was characterized using SDS±PAGE, dynamic light scattering using DynaPro-800 (Proterion), N-terminal sequencing and mass spectrometry. The peak fractions were pooled, concentrated to 4 mg ml À1 , aliquoted (400 ml),¯ash-frozen using liquid nitrogen and stored at 193 K.
Crystallization
The puri®ed aliquot of Pim-1 protein was thawed out and applied onto a pre-equilibrated Superdex-75 column (analytical, 30 ml resin) followed by elution using S buffer. The major peak fractions were pooled and concentrated to about 4 mg ml À1 for crystallization trials both as apoprotein and as an AMP-PNP (1 mg ml À1 ®nal concentration) complex against 96 sparse-matrix conditions (Hampton, HR2-132) and an in-house grid screen. The in-house grid was comprised of 48 conditions permuted from PEG 1500 (18, 24, 30, 36%) and PEG 4000 (12, 16, 20, 24%) at six different pH values (ADA for pH 6.0, 6.5; Tris for pH 7.0, 7.5, 8.0, 8.5). The screening was conducted using hanging drops consisting of 0.5 ml each of protein and well solutions. Larger crystals were obtained by optimization using hanging drops with 1.5 ml each of protein and well solutions. Crystals were grown at room temperature and the ®nal crystallization solution contained 30% PEG 1500, 0.1 M Tris pH 7.5 and 0.3 M NaCl.
Preliminary crystallographic analysis
Examination of crystal diffraction and data collection were conducted using an R-AXIS IV ++ imaging system mounted on a RU300 rotating-anode X-ray generator (Rigaku/MSC) at cryogenic temperature. The Pim-1 crystals were cryoprotected using well solution with the addition of 5% glycerol. The diffraction data were processed using the HKL2000 package (Otwinowski & Minor, 1997) .
Results and discussion
Initial attempts to express the GST-tagged Pim-1 gene using the pDEST15 gateway vector were unsuccessful and the data generated from these trials suggested that the construct was unstable (data not shown). The Pim-1 gene was then subcloned into the pET41a vector, which contains a constitutively expressed Lac IQ protein that decreases read-through expression during the growth phase. Expression of the GST-Pim1 construct from this vector was successful as described and was highly reproducible. In addition, the puri®cation protocol for Pim-1 was optimized by eliminating the buffer-exchange step normally required prior to ion-exchange chromatography. Trial experiments showed that both thrombin cleavage of Pim-1 and the binding of digested Pim-1 to the anion-exchange (Mono-Q) column could be carried out in low-salt QA buffer. Elimination of this step improved the overall ef®ciency of the protocol because buffer exchange is usually time-consuming and achieves no puri®cation. The divalent anions Mg 2+ and Ca 2+ were included in the SEC and the ®nal protein buffer as they were found to be bene®cial in stabilizing the Pim-2 protein (data not shown). Thrombin digestion in one step using 15 000 units of enzyme was also found to be as effective (data not shown) as two-step digestion as described above.
The encoded GST-fusion protein of human Pim-1 kinase contains one engineered and two endogenous thrombin-cleavage sites at LVPRÁGST (À48ÁÀ47), GYRÁGSEF (À5ÁÀ4) and HLRÁAAP (13Á14) between RÁG(A). Cleavage at these sites would produce three different proteins: Pim-1 (À47±313), Pim-1 (À4±313) and Pim-1 (14± 313), with expected molecular weights of about 40, 36 and 34 kDa, respectively. The initial digestion using 5000 units of thrombin produced a mixture of more than four protein species, three of which co-eluted on anion-exchange chromatography with molecular weights around 35 kDa (Fig. 1a) and possibly corresponded to Pim-1 species from different cleavage sites. Further digestion of the mixture using 10 000 units of thrombin increased the relative abundance of the 34 kDa protein, with the appearance of some extra thrombinrelated protein bands (Fig. 1b) . The extra protein bands after digestion were removed using anion-exchange chromatography (Fig. 1c) . This sample was further puri®ed by preparative SEC and produced a major peak with a retention volume corresponding to a monomeric Pim-1 protein. The major peak fractions were pooled and concentrated to about 4 mg ml
À1
, and yielded a total of about 24 mg Pim-1 protein.
The puri®ed protein was found to be highly homogeneous on SDS± PAGE (Fig. 1d) . The results from dynamic light scattering (Ferre-D'Amare & Burley, 1994 show that a fresh Pim-1 (14±313) sample is monodisperse (ÁR/R < 15%, baseline < 1.005) at concentrations up to 4 mg ml
, with a molecular weight around 40 kDa (Table 1) ; the results also suggest the presence of monomeric Pim-1 in solution. N-terminal sequencing shows there is only one protein species detectable in the puri®ed Pim-1 sample, with a sequence AAPWNDJHATMLAPG, exactly matching that of Pim-1 (14±313). Mass spectrometry shows a 70% parent-ion peak of 34 207 Da, an exact match with the calculated peak of 34 206 Da for Pim-1 (14± 313), and a 30% peak of 34 346 Da, possibly being a DTT adduct of Pim-1 (14±313). These results establish that human Pim-1 (14±313) kinase was obtained with high purity and monodispersity.
Pim-1 (14±313) protein becomes polydisperse (ÁR/R > 15%, baseline >1.005) after being subjected to a single freeze±thaw cycle (Table 1) . Because systematic studies show that monodisperse protein samples are more readily crystallized than polydisperse samples (Ferre-D'Amare & Burley, 1997), the frozen aliquots of the protein were repuri®ed through an analytical SEC column. The major peak was pooled and concentrated to about 4 mg ml À1 and was determined to be monodisperse again. All samples used for crystallization trials were repuri®ed using SEC. Small crystals were found in 17 of the 96 sparse-matrix conditions and 37 of the 48 in-house grid conditions with the presumed AMP-PNP complex, but in only two sparse-matrix conditions for the apoenzyme. Crystals obtained from samples containing AMP-PNP could not be made larger and were not used for structure studies; however, they were valuable as seeds for apoenzyme crystallization in conditions originally found in AMP-PNPcontaining trials. Since the morphology of the small crystals from the in-house grid conditions looked promising (Fig. 2a) , these conditions were used to start optimizing apo Pim crystallization coupled with seeding. Using modi®ed grid solutions containing 18% PEG 1500, 0.1 M Tris pH 7.5 and 0.2 M MgCl 2 or 30% PEG 1500, 0.1 M Tris pH 7.5 and 0.3 M NaCl (®nal), the apo protein yielded crystals with widths of 20 mm (Fig. 2b) or 40 mm (Fig. 2c ) that diffracted to 3.3 or 2.5 A Ê resolution, respectively.
Pim-1 (14±313) protein sample was still potentially contaminated by a trace amount of Pim-1 (À4±313) arising from incomplete digestion beyond the detection limits of the characterization techniques. We hypothesized that even minute amounts of Pim-1 (À4± 313) could potentially poison the crystal lattice of Pim-1 (14±313) and compromise crystal growth. Following this hypothesis, we repuri®ed the aliquoted pure Pim-1 sample twice using analytical SEC to further reduce the contamination. The twice repuri®ed Pim-1 sample yielded crystals of approximate dimensions 100 Â 100 Â 1000 mm (Fig. 2d ) using the ®nal crystallization condition that diffracted to 2.1 A Ê resolution. Seeding was necessary to grow large Pim-1 crystals (20, 40 or 100 mm) because the number of crystals in a drop was roughly correlated to the volume of seeding solution and no crystals were found if the drop was not seeded. The Pim-1 crystals of various sizes all belong to the same space group with very similar unit-cell parameters. The 20 mm crystals diffracted only weakly to 3.3 A Ê resolution, probably owing to both the smaller crystal size and the slightly longer a axis (data not shown). X-ray diffraction data were collected for the various sizes of Pim-1 crystals and the statistics of the 2.1 A Ê data are summarized in Table 2 . The data indicate a hexagonal space group, either P6 5 or P6 1 , with unit-cell parameters a = b = 95.9, c = 80.0 A Ê , = 120
. Assuming the presence of one molecule in the asymmetric unit, the Matthews volume (Matthews, 1968 ) was calculated to be 3.09 A Ê 3 Da
. The structure has been determined using molecular replacement in space group P6 5 (Qian et al., 2005 
